SEATTLE, WA – When biotech and pharmaceutical companies in one of America’s premier emerging life sciences hubs need specialized preclinical contract research organization (CRO) services, Anilocus delivers cutting-edge solutions that drive drug discovery forward. Providing preclinical CRO services to research teams located in the heart of Seattle’s dynamic biotech ecosystem, we provide comprehensive preclinical research support with the local accessibility and regulatory expertise your projects demand.
Your Local CRO Partner in the Pacific Northwest
Seattle stands out as one of the most dynamic biotech locations in the United States and was recognized as one of America’s premier emerging life sciences hubs in 2019. The city remains one of the top-ten biotech clusters in the US, home to biotech firms working in diverse areas including gene editing, oncology, antibody-drug conjugates, T-cell therapies, synthetic biology, and vaccine research. Most of the biotech companies in Washington are concentrated in the Seattle-Tacoma-Everett metropolitan area, with the South Lake Union neighborhood serving as the epicenter of the city’s burgeoning biotech corridor.
The region hosts world-class research institutions including the Fred Hutchinson Cancer Center, University of Washington, Institute for Systems Biology, Allen Institute for Brain Science, and Seattle Children’s Research Institute. Major pharmaceutical companies including Bristol Myers Squibb (employing more than 1,500 people in the region) have significant operations, alongside innovative biotech companies like Adaptive Biotechnologies, Sana Biotechnology, TwinStrand Biosciences, Umoja Biopharma, and A-Alpha Bio developing breakthrough therapies in immunology, synthetic biology, and precision medicine, all requiring specialized preclinical services to advance their drug development programs.
Why Seattle Biotech Choose Anilocus
- Collaborative network access – Established partnerships and working relationships with Seattle’s leading research institutions including Fred Hutch, University of Washington, and Institute for Systems Biology, enabling seamless knowledge transfer and access to specialized equipment
- Specialized in vivo capabilities – Advanced in vivo assessments and expertise that complement safety and efficacy therapeutics testing in the Pacific Northwest’s innovation-driven environment
- Integrated preclinical solutions – Comprehensive study design through regulatory submission support, reducing vendor management complexity and accelerating development timelines in one of America’s fastest-growing biotech clusters
CRO Excellence in America’s Emerging Biotech Hub
Anilocus specializes in preclinical research solutions that meet the demanding standards of Seattle’s pharmaceutical industry. Our capabilities span in vivo studies, behavioral neuroscience, advanced bioanalytics, and regulatory-compliant study execution. What sets us apart is our unique combination of scientific precision and custom fabrication capabilities, delivering exactly what your research requires in a city that has become a compelling destination for biotech innovation and investment.
Operating in Seattle means being part of a thriving ecosystem where more than 6,000 people work in state-of-the-art facilities designed with flexibility, collaboration, and sustainability in mind. Our preclinical studies are designed with this collaborative environment in mind, ensuring seamless integration with the region’s cutting-edge research infrastructure centered around the South Lake Union biotech corridor.
With Seattle’s biotechnology sector experiencing significant growth, particularly during the COVID-19 pandemic as many firms scaled operations for vaccine development, and the Seattle Hub for Synthetic Biology receiving $75 million in funding, the region continues to establish itself as a major player in biotechnology innovation. Anilocus is perfectly positioned to support this growth with specialized preclinical services that bridge the gap between laboratory discoveries and clinical applications in the Pacific Northwest’s premier biotech hub.
Ready to Accelerate Your Research?
Ready to advance your preclinical research with a CRO partner that understands the unique advantages and collaborative spirit of Seattle’s biotech ecosystem? From the innovation corridors of South Lake Union to the research facilities throughout the greater Seattle area, Anilocus delivers the scientific excellence that forward-thinking biotech companies demand.
Get Started Today!
Transform your research vision into actionable data with Anilocus, where scientific precision meets fabrication capability for real research impact in the Pacific Northwest’s premier biotech destination. Contact us today and speak to a scientist!
